Functional genetics of APR-246 rescuable TP53 mutants

被引：0
|
作者：
Saunders, Anais
Tong, Caili
Karnezis, Anthony N.
Leiserowitz, Gary S.
Chein, Jeremy R.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-631
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
631
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer
    Åsa Fransson
    Daria Glaessgen
    Jessica Alfredsson
    Klas G. Wiman
    Svetlana Bajalica-Lagercrantz
    Nina Mohell
    Journal of Ovarian Research, 9
  • [22] APR-246 INDUCES AN INCREASE IN TUMOR IMMUNOGENICITY IN A P53 INDEPENDENT MANNER
    Venkatesh, Divya
    Michels, Judith
    Lu, Cailin
    Budhu, Sadna
    George, Mariam
    Ouerfelli, Ouathek
    Abrahmsen, Lars
    Zappasodi, Roberta
    Wolchok, Jedd
    Merghoub, Taha
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A941 - A941
  • [23] Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer
    Fransson, Asa
    Glaessgen, Daria
    Alfredsson, Jessica
    Wiman, Klas G.
    Bajalica-Lagercrantz, Svetlana
    Mohell, Nina
    JOURNAL OF OVARIAN RESEARCH, 2016, 9
  • [24] APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
    Qiang Zhang
    Vladimir J. N. Bykov
    Klas G. Wiman
    Joanna Zawacka-Pankau
    Cell Death & Disease, 9
  • [25] APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
    Zhang, Qiang
    Bykov, Vladimir J. N.
    Wiman, Klas G.
    Zawacka-Pankau, Joanna
    CELL DEATH & DISEASE, 2018, 9
  • [26] APR-246 Combined with Azacitidine (AZA) in TP53 Mutated Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML). a Phase 2 Study By the Groupe Francophone Des Myelodysplasies (GFM)
    Cluzeau, Thomas
    Sebert, Marie
    Rahme, Ramy
    Cuzzubbo, Stefania
    Walter-petrich, Anouk
    Che, Jacqueline Lehmann
    Peterlin, Pierre
    Beve, Blandine
    Attalah, Habiba
    Chermat, Fatiha
    Miekoutima, Elsa
    Beyne-Rauzy, Odile
    Recher, Christian
    Stamatoullas, Aspasia
    Willems, Lise
    Raffoux, Emmanuel
    Berthon, Celine
    Quesnel, Bruno
    Carpentier, Antoine
    Sallman, David A.
    Chevret, Sylvie
    Ades, Lionel
    Fenaux, Pierre
    BLOOD, 2019, 134
  • [27] APR-246 targets pediatric acute lymphoblastic leukemia carrying mutant P53
    Demir, S.
    Selivanova, G.
    Tausch, E.
    Wiesmueller, L.
    Stilgenbauer, S.
    te Kronnie, G.
    Debatin, K. -M.
    Meyer, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 117 - 117
  • [28] Correction: APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
    Qiang Zhang
    Vladimir J. N. Bykov
    Klas G. Wiman
    Joanna Zawacka-Pankau
    Cell Death & Disease, 10
  • [29] APR-246 induces apoptosis and enhances chemo-sensitivity via activation of ROS and TAp73-Noxa signal in oesophageal squamous cell cancer with TP53 missense mutation
    Teruyuki Kobayashi
    Tomoki Makino
    Kotaro Yamashita
    Takuro Saito
    Koji Tanaka
    Tsuyoshi Takahashi
    Yukinori Kurokawa
    Makoto Yamasaki
    Kiyokazu Nakajima
    Eiichi Morii
    Hidetoshi Eguchi
    Yuichiro Doki
    British Journal of Cancer, 2021, 125 : 1523 - 1532
  • [30] APR-246 induces apoptosis and enhances chemo-sensitivity via activation of ROS and TAp73-Noxa signal in oesophageal squamous cell cancer with TP53 missense mutation
    Kobayashi, Teruyuki
    Makino, Tomoki
    Yamashita, Kotaro
    Saito, Takuro
    Tanaka, Koji
    Takahashi, Tsuyoshi
    Kurokawa, Yukinori
    Yamasaki, Makoto
    Nakajima, Kiyokazu
    Morii, Eiichi
    Eguchi, Hidetoshi
    Doki, Yuichiro
    BRITISH JOURNAL OF CANCER, 2021, 125 (11) : 1523 - 1532
12345